- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on New-onset type1 Diabetes in Austria
Total 694 results
-
Intarcia TherapeuticsTerminatedType 2 DiabetesUnited States
-
Medtronic DiabetesActive, not recruitingType 1 DiabetesUnited States, Canada, Australia
-
Medtronic DiabetesCompletedType 1 DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Sweden, Norway, Germany, Australia
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
ResMedRoyal North Shore Hospital; International Diabetes Center at Park Nicollet; Baker...CompletedDiabetes Mellitus Type 2United States, Australia, Canada
-
Eli Lilly and CompanyCompletedType 2 DiabetesChina, Australia, Korea, Republic of, India
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, Australia, Taiwan, Thailand, Hong Kong, Singapore, Philippines
-
Medtronic DiabetesEli Lilly and CompanyCompletedType 1 DiabetesUnited States
-
NovartisCompletedType 2 Diabetes MellitusGermany, Romania, Hungary, Belgium, Slovakia, Australia, India, Czech Republic, Guatemala, Hong Kong, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Bulgaria, Russian Federation, United Kingdom, Hungary, Romania, Finland, Canada, Austria, Germany, Netherlands, Slovakia, Spain
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Brazil, Germany, Israel, Italy, United Kingdom, Australia, Hungary, Puerto Rico, Romania, Russian Federation, Spain, Poland, Canada, Greece, Turkey, Mexico, New Zealand, South Africa, Argentina, Finland, Lithuania, Sl...
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Canada, Austria, Japan, Norway, Puerto Rico
-
Novo Nordisk A/SRecruitingType 2 Diabetes MellitusKorea, Republic of, United States, Hungary, Serbia, Spain, China, Australia, Finland, United Kingdom, Italy, Denmark, Canada, Taiwan, Poland, Germany, Sweden, South Africa, India, Argentina, Brazil, Bulgaria, Japan, Mexico, Turkey, Greece, Colomb... and more
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Australia, United Kingdom, Mexico, Argentina, Brazil, Israel, Canada
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Puerto Rico
-
Bristol-Myers SquibbCompletedDiabetes, Type 2United States, Canada, Mexico, Puerto Rico, Australia, Poland, Taiwan
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, South Africa, Spain, Turkey, China, Netherlands, Argentina, Austria, Czechia, United Arab Emirates, Taiwan, India, Egypt, Saudi Arabia, Lebanon, Indonesia, Col... and more
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada, Romania, Russian Federation, Ukraine, Germany, Spain, Philippines, Czech Republic, Mexico, Croatia, Chile, Morocco, South Africa, Australia, Venezuela
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Israel, Poland, United Kingdom, Denmark, Spain, France, Austria, Norway, Russian Federation, Canada, Croatia, Argentina, South Africa, Australia, Ireland, Brazil, Finland
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Romania, Mexico, United States, Bulgaria, Germany, Latvia, Lithuania, Guatemala
-
Medical University of GrazJuvenile Diabetes Research FoundationRecruitingDiabetes Mellitus, Type 1United Kingdom, Belgium, Poland, Austria, France, Germany, Italy
-
Robert LodderUniversity of KentuckyCompleted
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
-
University of GlasgowJuvenile Diabetes Research Foundation; Maastricht University Medical Center; University... and other collaboratorsCompletedDiabetes Mellitus, Type 1United Kingdom, Netherlands, Australia, Canada, Denmark
-
HighTide Biopharma Pty LtdCompletedDigestive System Diseases | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Type 2 Diabetes Mellitus (T2DM) | Fatty Liver, NonalcoholicUnited States
-
Eli Lilly and CompanyActive, not recruitingType 2 Diabetes MellitusChina, United States, Netherlands, Spain, Australia, Austria, India, Canada, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Italy, Argentina, Brazil, Puerto Rico, Ukraine, Hungary, Czechia, Turkey, Korea, Republic... and more
-
Bayside HealthCompletedObesity | Insulin Resistance | Type 2 DiabetesAustralia
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Spain, Canada, United States, Germany, United Kingdom
-
Baker Heart Research InstituteUnknownObesity | Metabolic Syndrome | Type 2 DiabetesAustralia
-
Novo Nordisk A/SWithdrawnDiabetes Mellitus, Type 2United States, Sweden, Austria, Finland
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, Austria, South Africa
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Denmark, Croatia, Australia, South Africa, Italy, Sweden
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Canada, Czechia, Denmark, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Taiwan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Hungary, France, Australia
-
Repros Therapeutics Inc.CompletedType 2 Diabetes Mellitus | Secondary HypogonadismUnited States
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, China, Italy, Japan, India, Poland, South Africa, Turkey, Greece, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Malaysia, South Africa, Philippines, Australia, India, Saudi Arabia
-
Medtronic DiabetesRecruitingType 1 DiabetesUnited States, Spain, New Zealand, Canada, France, Germany, Italy, Sweden, United Kingdom
-
SanofiCompletedDiabetes Mellitus Type 2United States, Austria, Canada, France, Germany, Greece, Guatemala, India, Mexico, Peru, Puerto Rico, Romania, Turkey
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Canada, Denmark, Netherlands, Sweden
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
Diasome PharmaceuticalsCompletedDiabetes Mellitus, Type 1United States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Hungary, Greece, Germany, Turkey, Romania, Czech Republic, Slovakia, Austria, Poland
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Finland, South Africa, Canada, Mexico, Chile, Spain, Russian Federation, France, Germany, Hungary, Portugal, Romania
-
Milton S. Hershey Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsNot yet recruitingDiabetes Mellitus, Type 1United States, Australia, United Kingdom
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Mexico, Taiwan, United States, Israel, Russian Federation, Slovakia, Ukraine, Guatemala, Peru, Romania